A detailed history of Abrdn PLC transactions in Pfizer Inc stock. As of the latest transaction made, Abrdn PLC holds 4,425,562 shares of PFE stock, worth $124 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,425,562
Previous 4,469,299 0.98%
Holding current value
$124 Million
Previous $129 Million 4.56%
% of portfolio
0.25%
Previous 0.28%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $1.13 Million - $1.3 Million
-43,737 Reduced 0.98%
4,425,562 $123 Million
Q4 2023

Jan 31, 2024

BUY
$26.13 - $33.94 $60.7 Million - $78.8 Million
2,321,671 Added 108.1%
4,469,299 $129 Million
Q3 2023

Nov 06, 2023

SELL
$32.09 - $37.51 $503,203 - $588,194
-15,681 Reduced 0.72%
2,147,628 $71.2 Million
Q2 2023

Jun 20, 2024

BUY
$36.12 - $41.79 $352,711 - $408,079
9,765 Added 0.45%
2,163,309 $79.4 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $352,711 - $408,079
9,765 Added 0.45%
2,163,309 $79.4 Million
Q1 2023

Jun 20, 2024

BUY
$39.39 - $51.28 $6.61 Million - $8.6 Million
167,700 Added 8.44%
2,153,544 $87.9 Million
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $6.61 Million - $8.6 Million
167,700 Added 8.44%
2,153,544 $87.9 Million
Q4 2022

Jun 20, 2024

SELL
$41.75 - $54.5 $102 Million - $133 Million
-2,439,718 Reduced 55.13%
1,985,844 $102 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $4.99 Million - $6.52 Million
119,622 Added 6.41%
1,985,844 $102 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $9.67 Million - $11.8 Million
220,891 Added 13.43%
1,866,222 $81.7 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $2.72 Million - $3.22 Million
-58,429 Reduced 3.43%
1,645,331 $85.5 Million
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $50.8 Million - $62.9 Million
-1,110,387 Reduced 39.46%
1,703,760 $89.2 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $776,526 - $1.15 Million
-18,793 Reduced 0.66%
2,814,147 $166 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $2.64 Million - $3.39 Million
-67,266 Reduced 2.32%
2,832,940 $123 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $7.59 Million - $8.6 Million
-211,308 Reduced 6.79%
2,900,206 $114 Million
Q1 2021

May 06, 2021

BUY
$33.49 - $37.77 $16.4 Million - $18.5 Million
489,816 Added 18.68%
3,111,514 $113 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $1.96 Million - $2.49 Million
-58,497 Reduced 2.18%
2,621,698 $96.5 Million
Q3 2020

Oct 21, 2020

SELL
$31.75 - $37.25 $9.98 Million - $11.7 Million
-314,340 Reduced 10.5%
2,680,195 $98.4 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $2.81 Million - $3.41 Million
93,414 Added 3.22%
2,994,535 $97.9 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $18.1 Million - $25.9 Million
-669,470 Reduced 18.75%
2,901,121 $94.7 Million
Q4 2019

Feb 18, 2020

SELL
$32.92 - $37.36 $13.2 Million - $15 Million
-400,701 Reduced 10.09%
3,570,591 $140 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $28.7 Million - $37.2 Million
-883,689 Reduced 18.2%
3,971,292 $143 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $31.7 Million - $35.6 Million
-856,649 Reduced 15.0%
4,854,981 $210 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $205 Million - $226 Million
-5,475,291 Reduced 48.94%
5,711,630 $243 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $12.9 Million - $14.7 Million
-335,723 Reduced 2.91%
11,186,921 $479 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $20.7 Million - $25.1 Million
-601,000 Reduced 4.96%
11,522,644 $508 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $18.5 Million - $19.8 Million
562,079 Added 4.86%
12,123,644 $440 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $17.7 Million - $20.5 Million
-554,134 Reduced 4.57%
11,561,565 $410 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $16 Million - $17 Million
-480,935 Reduced 3.82%
12,115,699 $439 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $390 Million - $430 Million
12,596,634
12,596,634 $450 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.